When we first launched Every Heartbeat Matters (EHM), Edwards Lifesciences' philanthropic initiative, back in 2014, we knew that we had set an ambitious goal - to impact the global burden of heart valve disease by supporting the education, screening and treatment of one million underserved people by 2020.
HEALTHCARE: Light therapy firm does $10M, expects more
The future looks bright for Anaheim’s Biophotas Inc., a leading light in Orange County’s growing aesthetics industry.
DRUGMAKERS: Bill Link on firm’s board
Irvine-based Tarsus Pharmaceuticals, which is backed by Orange County’s best-known ophthalmology venture capital executive, Bill Link, and several other notable area investors, has raised $60 million to continue testing a drug that aims to be the first of its type to treat a common disease affecting the eye.
EDUCATION: New initiative emphasizes multi-disciplines
University of California-Irvine in 1964 was the first department of neuroscience in the U.S., which meant it was first to be studying the brain in an academic setting.
2nd Building at Tustin Education Park
ACS Development Group Inc. plans to build a 50,000-square-foot medical office building in Tustin, the newest sign of construction at the Advanced Technology Education Park on the former Marine base.
EDUCATION: UCI professors discuss state of market
Editor’s Note: California’s legalization of cannabis has created opportunity in Orange County as serious investors have told the Business Journal they are looking to invest in the industry, from real estate to research to starting companies.
ChromaDex Corp. said health regulatory body the Australian Therapeutic Goods Administration approved its nicotinamide riboside chloride “for use in listed complementary medicines” with “market exclusivity” for two years.